A human antibody against human endothelin receptor type A that exhibits antitumor potency
Man‐Seok Ju(Korea University), Sang Taek Jung(Seoul National University)
Cited by 21
Related Papers
Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering
|BioDrugs|2021|58
A short PEG linker alters the <i>in vivo</i> pharmacokinetics of trastuzumab to yield high-contrast immuno-PET images
|Journal of Materials Chemistry B|2021|25
Correction: A short PEG linker alters the <i>in vivo</i> pharmacokinetics of trastuzumab to yield high-contrast immuno-PET images
|Journal of Materials Chemistry B|2021|2